CVS Caremark (CVS) Tops Q1 EPS by 2c; Boosts FY12 adj.-EPS Outlook; Guides Q2
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $101.30 +3.03%
EPS Growth %: +1.1%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +1.1%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q1 EPS of $0.65, $0.02 better than the analyst estimate of $0.63. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $30.31 billion.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- CVS Health expands GLP-1 access with $49 virtual visits, Medicare cap
- Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
